Search filters

List of works by Karl Ljungberg

Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.

scientific article

Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus

scientific article published on 23 March 2017

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

scientific article published on November 2008

DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity.

scientific article published on 14 December 2010

DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes

scientific article published in May 2002

Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins

scientific article published on 7 March 2018

Effective construction of DNA vaccines against variable influenza genes by homologous recombination.

scientific article

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

scientific article published in October 2002

Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids

scientific article published on June 2, 2003

H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice

scientific article

HIV subtypes and recombination strains--strategies for induction of immune responses in man.

scientific article

HIV vaccine development: the myth of Sisyphus modernized?

article

Host gene expression signatures discriminate between ferrets infected with genetically similar H1N1 strains

scientific article

Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

scientific article published on 17 July 2014

Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma

scientific article

Intradermal Electroporation of RNA

scientific article published on 01 January 2014

Intradermal electroporation of naked replicon RNA elicits strong immune responses

scientific article (publication date: 2012)

Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations

scientific article

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

scientific article

Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication.

scientific article

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques.

scientific article

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.

scientific article published in July 2004

Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery

scientific article

Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV

scientific article published on 21 March 2019

Primary murine cells as a model for HIV-1 infection.

scientific article published on April 2004

Self-replicating alphavirus RNA vaccines.

scientific article published on October 2014

Subtypes A, C, G, and recombinant HIV type 1 are circulating in Bangladesh

scientific article published in June 2002

Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine

scientific article published on 8 February 2012

The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon

scientific article

Therapeutic vaccines against cancer and infectious diseases. Great possibilities in the research--small clinical progress so far

scientific article published in September 2008

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.

scientific article published in April 2004

Vaccine delivery methods using viral vectors

scientific article published on January 2007